Pathophysiological Role and Clinical Significance of Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) Bound to LDL and HDL

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|20|40|6256-6269

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.40, 2014-12, pp. : 6256-6269

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Modulation of Lipoprotein-associated Phospholipase A2 (Lp-PLA2)

By  

Current Pharmaceutical Design, Vol. 17, Iss. 33, 2011-11 ,pp. : 3656-3661

Bentham Science Publishers

Access to resources Recommend Favorite

Lipoprotein-associated Phospholipase A2 and Coronary Heart Disease

By  

Current Pharmaceutical Design, Vol. 24, Iss. 3, 2018-04 ,pp. : 291-296

Bentham Science Publishers

Access to resources Recommend Favorite

Lipoprotein-associated phospholipase A2: a target directed at the atherosclerotic plaque

By Macphee Colin H   Suckling Keith E  

Expert Opinion on Therapeutic Targets, Vol. 6, Iss. 3, 2002-06 ,pp. : 309-314

Informa Healthcare

Access to resources Recommend Favorite

Darapladib has a hearty effect on Lp-PLA2 activity

By  

Inpharma, Vol. 1, Iss. 1637, 2008-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Simvastatin Reduces Expression and Activity of Lipoprotein-associated Phospholipase A2 in the Aorta of Hypercholesterolaemic Atherosclerotic Rabbits

By Qiao Z   Ren J   Chen H  

The Journal of International Medical Research, Vol. 37, Iss. 4, 2009-07 ,pp. : 1029-1037

Field House Publishing

Access to resources Recommend Favorite